Accessibility Menu
 
Ventripoint Diagnostics logo

Ventripoint Diagnostics

(OTC) VPTDF

Current Price$0.13
Market Cap$24.32M
Since IPO (2011)-94%
5 Year-68%
1 Year+33%
1 Month+59%

Ventripoint Diagnostics Financials at a Glance

Market Cap

$24.32M

Revenue (TTM)

$175.62K

Net Income (TTM)

$4.06M

EPS (TTM)

$-0.02

P/E Ratio

-7.32

Dividend

$0.00

Beta (Volatility)

0.57 (Low)

Price

$0.13

Volume

820,546

Open

$0.11

Previous Close

$0.13

Daily Range

$0.11 - $0.13

52-Week Range

$0.06 - $0.13

VPTDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

Industry

Healthcare Equipment and Supplies

CEO

Hugh MacNaught

Headquarters

Toronto, ON M6P 1T4, CA

VPTDF Financials

Key Financial Metrics (TTM)

Gross Margin

83%

Operating Margin

-21%

Net Income Margin

-23%

Return on Equity

0%

Return on Capital

82%

Return on Assets

-11%

Earnings Yield

-13.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.32M

Shares Outstanding

187.66M

Volume

820.55K

Avg. Volume

94.23K

Financials (TTM)

Gross Profit

$95.17K

Operating Income

$4.80M

EBITDA

$4.76M

Operating Cash Flow

$3.39M

Capital Expenditure

$0.00

Free Cash Flow

$3.39M

Cash & ST Invst.

$60.55K

Total Debt

$1.63M

Ventripoint Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$104.30K

+61.7%

Gross Profit

$104.30K

+61.7%

Gross Margin

100.00%

N/A

Market Cap

$24.32M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$752.08K

+39.9%

EBITDA

$616.56K

+47.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.28M

-71.4%

Accounts Receivable

$124.48K

-41.5%

Inventory

$0.00

N/A

Long Term Debt

$140.87K

-89.3%

Short Term Debt

$2.21M

+1657.9%

Return on Assets

-10.77%

N/A

Return on Invested Capital

82.19%

N/A

Free Cash Flow

$68.71K

+90.1%

Operating Cash Flow

$68.71K

+90.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LUFFFHerbal Dispatch Inc.
$0.05+5.08%
ASAPFAurora Spine Corporation
$0.19-4.97%
NUMIFNuminus Wellness Inc.
$0.03+24.38%
BTCYBiotricity, Inc.
$0.26+11.83%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$99.62+0.05%
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%

Questions About VPTDF

What is the current price of Ventripoint Diagnostics?

Ventripoint Diagnostics is trading at $0.13 per share.

What is the 52-week range for Ventripoint Diagnostics?

Over the past 52 weeks, Ventripoint Diagnostics has traded between $0.06 and $0.13.

How much debt does Ventripoint Diagnostics have?

As of the most recent reporting period, Ventripoint Diagnostics reported total debt of $1.69M.

How much cash does Ventripoint Diagnostics have on hand?

Ventripoint Diagnostics reported $49,103.062 in cash and cash equivalents in its most recent financial results.

What is Ventripoint Diagnostics’s dividend yield?

Ventripoint Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.